Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528372 | Clinical Therapeutics | 2017 | 12 Pages |
Abstract
Although GEPNETs are slow-growing tumors, most patients are diagnosed with metastatic disease, and therefore it is important that the management of each patient be discussed in a multidisciplinary setting to optimize the treatment strategy. Patients should be considered for clinical trials and refractory cases referred to a specialty center.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Gurleen MD, Parikshit MD, Nour MD, Dulabh K. MD,